The development of global consensus guidelines on the management and prevention of the diabetic foot 2011

被引:84
作者
Bakker, K. [1 ]
Schaper, N. C. [2 ,3 ]
机构
[1] Int Working Grp Diabet Foot, NL-2102 KN Heemstede, Netherlands
[2] Maastricht Univ, Med Ctr, Dept Internal Med, Div Endocrinol Res,Sch CAPHRI, Maastricht, Netherlands
[3] Maastricht Univ, Med Ctr, Dept Internal Med, Div Endocrinol Res,Sch CARIM, Maastricht, Netherlands
关键词
diabetic foot; foot ulcers; guidelines; IWGDF; implementation; consensus; development of global guidelines; ULCERS;
D O I
10.1002/dmrr.2254
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Diabetic foot ulcers are the source of major suffering and very large costs for both the patient and the health-care system, and every 30?s, a leg is lost somewhere in the world. Investing in a diabetic foot care guideline can therefore be one of the most cost-effective forms of health-care expenditure, provided the guideline is goal focused and properly implemented. The objective of the International Working Group on the Diabetic Foot (IWGDF) is to develop guidelines that will reduce the effect of diabetic foot disease through cost-effective and quality health care, based on the principles of evidence-based medicine. These guidelines are produced by working groups of experts in the field and are endorsed by the more than 100 country representatives of the IWGDF. In 2009, the IWGDF invited again three working groups to write consensus guidelines on peripheral arterial disease, infection, and wound healing. New texts were produced according to a systematic review of the literature in order to inform protocols for routine care and to highlight areas that should be considered for further study. During a meeting of the members of the IWGDF in May 2011, the new set of guidelines was approved and is published in this journal. Copyright (C) 2012 John Wiley & Sons, Ltd.
引用
收藏
页码:116 / 118
页数:3
相关论文
共 12 条
[1]
[Anonymous], DIAB ATL
[2]
The development of global consensus guidelines on the management of the diabetic foot [J].
Apelqvist, J. ;
Bakker, K. ;
van Houtum, W. H. ;
Schaper, N. C. ;
Board, Int People Working Grp Diabetic Foot Editorial .
DIABETES-METABOLISM RESEARCH AND REVIEWS, 2008, 24 :S116-S118
[3]
Bakker K., 2005, TIME ACT DIABETES FO
[4]
The global burden of diabetic foot disease [J].
Boulton, AJM ;
Vileikyte, L ;
Ragnarson-Tennvall, G ;
Apelqvist, J .
LANCET, 2005, 366 (9498) :1719-1724
[5]
The diabetic foot: from art to science - The 18th Camillo Golgi lecture [J].
Boulton, AJM .
DIABETOLOGIA, 2004, 47 (08) :1343-1353
[6]
Clinical Guidelines Task Force, 2003, GUID GUID GUID CLIN
[7]
A new system for grading recommendations in evidence based guidelines [J].
Harbour, R ;
Miller, J .
BRITISH MEDICAL JOURNAL, 2001, 323 (7308) :334-336
[8]
Assessing the outcome of the management of diabetic foot ulcers using ulcer-related and person-related measures [J].
Jeffcoate, William J. ;
Chipchase, Susan Y. ;
Ince, Paul ;
Game, Fran L. .
DIABETES CARE, 2006, 29 (08) :1784-1787
[9]
Health-related quality of life of diabetic foot ulcer patients and their caregivers [J].
Nabuurs-Franssen, MH ;
Huijberts, MSP ;
Kruseman, ACN ;
Willems, J ;
Schaper, NC .
DIABETOLOGIA, 2005, 48 (09) :1906-1910
[10]
Resource utilisation and costs associated with the treatment of diabetic foot ulcers. Prospective data from the Eurodiale Study [J].
Prompers, L. ;
Huijberts, M. ;
Schaper, N. ;
Apelqvist, J. ;
Bakker, K. ;
Edmonds, M. ;
Holstein, P. ;
Jude, E. ;
Jirkovska, A. ;
Mauricio, D. ;
Piaggesi, A. ;
Reike, H. ;
Spraul, M. ;
Van Acker, K. ;
Van Baal, S. ;
Van Merode, F. ;
Uccioli, L. ;
Urbancic, V. ;
Tennvall, G. Ragnarson .
DIABETOLOGIA, 2008, 51 (10) :1826-1834